Safety Study of a Liposomal Vaccine to Treat Malignant Melanoma

This study has been completed.
Sponsor:
Collaborators:
Royal Adelaide Hospital
Trident Clinical Research Pty Ltd
Information provided by (Responsible Party):
Lipotek Pty Ltd
ClinicalTrials.gov Identifier:
NCT01052142
First received: January 18, 2010
Last updated: April 10, 2012
Last verified: April 2012
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: March 2012
  Primary Completion Date: March 2012 (Final data collection date for primary outcome measure)